Simplicity Wealth’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$938K Buy
5,984
+544
+10% +$81.6K 0.03% 441
2026
Q1
$831K Buy
5,440
+303
+6% +$46.4K 0.05% 331
2025
Q4
$708K Buy
5,137
+145
+3% +$19K 0.04% 354
2025
Q3
$640K Sell
4,992
-3,594
-42% -$439K 0.04% 391
2025
Q2
$1.04M Buy
8,586
+5,016
+141% +$565K 0.04% 325
2025
Q1
$398K Sell
3,570
-51
-1% -$5.43K 0.03% 378
2024
Q4
$352K Buy
3,621
+1,244
+52% +$133K 0.07% 207
2024
Q3
$273K Sell
2,377
-59,192
-96% -$6.72M 0.03% 402
2024
Q2
$6.55M Buy
61,569
+6,855
+13% +$688K 0.15% 146
2024
Q1
$5.29M Buy
+54,714
New +$5.61M 0.13% 161

Other funds holding NVS

Simplicity Wealth's NVS Position: Q2 2026 in Review

Simplicity Wealth increased its Novartis (NVS) stake by 10% in Q2 2026, buying an estimated $81.6K and bringing the position to 5,984 shares worth $938K. The position accounts for 0.03% of the portfolio, ranked #441.

Simplicity Wealth first reported a position in NVS in Q1 2024 and has held it in 10 quarters since. The position peaked at $6.55M in Q2 2024. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Simplicity Wealth held 5,984 shares of Novartis worth $938K as of Q2 2026.
  • Simplicity Wealth bought 544 Novartis shares in Q2 2026, an estimated $81.6K.
  • Novartis made up 0.03% of Simplicity Wealth's portfolio in Q2 2026, its #441 holding.
  • Simplicity Wealth first reported a position in Novartis in Q1 2024 and has held it in 10 quarters since.
  • Simplicity Wealth's Novartis position peaked at $6.55M in Q2 2024.
  • 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Simplicity Wealth's 13F filing for Q2 2026, filed 6 Aug 2026.